Dissecting Isoform Selectivity of PI3 Kinase Inhibitors.Uncovering leads for rational drug design

  • Thompson, Philip (Primary Chief Investigator (PCI))
  • Amzel, L Mario (Chief Investigator (CI))
  • Jennings, Ian (Chief Investigator (CI))
  • Vogelstein, Bert (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date5/01/0930/09/12

Funding

  • National Health & Medical Research Council (NHMRC)
  • National Health & Medical Research Council (NHMRC): AUD499,500.00